Company Adaptive Biotechnologies Corporation
Equities
ADPT
US00650F1093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 USD | +0.38% | +11.78% | -46.73% |
Business Summary
Number of employees: 709
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Minimal Residual Disease - Service
60.3
%
| 81 | 43.8 % | 103 | 60.3 % | +26.61% |
Immune Medicine - Collaboration
25.0
%
| 66 | 35.8 % | 43 | 25.0 % | -35.86% |
Immune Medicine - Service
14.7
%
| 32 | 17.1 % | 25 | 14.7 % | -21.46% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 185 | 100.0 % | 170 | 100.0 % | -8.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Harlan Robins
FOU | Founder | 51 | 09-09-07 |
Chad Robins
CEO | Chief Executive Officer | 49 | 09-09-07 |
Kyle Piskel
DFI | Director of Finance/CFO | 40 | 21-10-27 |
Julie Rubinstein
PSD | President | 52 | 11-03-31 |
Zhou Yi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Public Communications Contact | - | - | |
Stacy Taylor
LAW | General Counsel | 64 | 19-02-28 |
Sharon Benzeno
PRN | Corporate Officer/Principal | 50 | 14-08-31 |
Francis Lo
HRO | Human Resources Officer | 43 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 13-01-31 |
Peter Neupert
BRD | Director/Board Member | 68 | 13-12-31 |
Michael Pellini
BRD | Director/Board Member | 58 | 18-02-12 |
Chad Robins
CEO | Chief Executive Officer | 49 | 09-09-07 |
Michelle Griffin
BRD | Director/Board Member | 58 | 19-02-28 |
Katey Owen
BRD | Director/Board Member | 55 | 21-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 145,092,271 | 140,878,850 ( 97.10 %) | 0 | 97.10 % |
Company contact information
Adaptive Biotechnologies Corp.
1165 Eastlake Avenue East
98109, Seattle
+206 659 0067
http://www.adaptivebiotech.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.73% | 377M | |
-20.53% | 11.48B | |
+41.94% | 3.27B | |
-36.56% | 2.2B | |
-18.92% | 2.05B | |
-29.19% | 1.49B | |
+15.73% | 1.01B | |
-4.37% | 743M | |
-37.00% | 413M | |
+16.90% | 374M |
- Stock Market
- Equities
- ADPT Stock
- Company Adaptive Biotechnologies Corporation